These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7082543)

  • 1. Saliva concentrations of lignocaine in healthy volunteers.
    Kanto J; Sellman R; Laurikainen E
    Br J Clin Pharmacol; 1982 May; 13(5):736-7. PubMed ID: 7082543
    [No Abstract]   [Full Text] [Related]  

  • 2. Saliva concentrations of lignocaine in patients with acute myocardial ischaemia.
    Laurikainen E; Kanto J
    Br J Clin Pharmacol; 1983 Aug; 16(2):199-200. PubMed ID: 6615695
    [No Abstract]   [Full Text] [Related]  

  • 3. Saliva concentrations of lidocaine and its metabolites in man.
    Barchowsky A; Stargel WW; Shand DG; Routledge PA
    Ther Drug Monit; 1982; 4(4):335-9. PubMed ID: 7157457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereospecific salivary excretion of tocainide enantiomers in man.
    Pillai GK; Axelson JE; Kerr CR; McErlane KM
    Res Commun Chem Pathol Pharmacol; 1984 Feb; 43(2):209-21. PubMed ID: 6424192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ultrasound on the percutaneous absorption of lignocaine.
    McElnay JC; Matthews MP; Harland R; McCafferty DF
    Br J Clin Pharmacol; 1985 Oct; 20(4):421-4. PubMed ID: 4074611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of ranitidine on the disposition of lignocaine.
    Feely J; Guy E
    Br J Clin Pharmacol; 1983 Mar; 15(3):378-9. PubMed ID: 6133546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impairment of lignocaine clearance by propranolol--major contribution from enzyme inhibition.
    Bax ND; Tucker GT; Lennard MS; Woods HF
    Br J Clin Pharmacol; 1985 May; 19(5):597-603. PubMed ID: 2860914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral lignocaine: its absorption and effectiveness in ventricular arrhythmia control.
    Parkinson PI; Margolin L; Dickson DS
    Br Med J; 1970 Apr; 2(5700):29-30. PubMed ID: 5440571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of age and smoking on the plasma protein binding of lignocaine and diazepam.
    Davis D; Grossman SH; Kitchell BB; Shand DG; Routledge PA
    Br J Clin Pharmacol; 1985 Feb; 19(2):261-5. PubMed ID: 3986083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption of lignocaine and bupivacaine from the respiratory tract during fibreoptic bronchoscopy.
    McBurney A; Jones DA; Stanley PJ; Ward JW
    Br J Clin Pharmacol; 1984 Jan; 17(1):61-6. PubMed ID: 6691889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications in correlation studies between serum, free serum and saliva concentrations of nitrazepam.
    Hart BJ; Wilting J; de Gier JJ
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):127-31. PubMed ID: 3586770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of lignocaine in the elderly [proceedings].
    Cusack B; Kelly JG; Lavan J; Noel J; O'Malley K
    Br J Clin Pharmacol; 1980 Mar; 9(3):293P-294P. PubMed ID: 7362749
    [No Abstract]   [Full Text] [Related]  

  • 15. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
    Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
    Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
    Miners JO; Wing LM; Lillywhite KJ; Smith KJ
    Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can lignocaine kinetics be predicted? [proceedings].
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1978 Nov; 6(5):441P-442P. PubMed ID: 728292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.